Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, November 13, 2023
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
Alex Thompson Downgraded (ACRS) to Hold and Decreased Target to $2 on, Nov 13th, 2023
Alex Thompson of Stifel, Downgraded "Aclaris Therapeutics, Inc." (ACRS) to Hold and Decreased Target from $20 to $2 on, Nov 13th, 2023.
Alex has made no other calls on ACRS in the last 4 months.
There are 3 other peers that have a rating on ACRS. Out of the 3 peers that are also analyzing ACRS, 0 agree with Alex's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Alex
- Louise Chen of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $38 on, Monday, October 9th, 2023
- Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $43 on, Wednesday, October 4th, 2023
- Gavin Clark-Gartner of "Evercore ISI Group" Initiated at Buy and Held Target at $22 on, Tuesday, October 3rd, 2023
